Skip to main content
logo
Greenwich LifeSciences, Inc. (GLSI)
NASDAQ: GLSI · Real-Time Price · USD
16.13
+0.18 (1.13%)
Sep 8, 2026, 11:57 AM EDT - Market open

Greenwich LifeSciences Balance Sheet

Millions USD. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
8.886.184.096.9913.4727.2
Cash & Short-Term Investments
8.886.184.096.9913.4727.2
Cash Growth
184.03%50.98%-41.45%-48.10%-50.49%-5.08%
Total Current Assets
8.886.184.096.9913.4727.2
Other Intangible Assets
--00.010.010.01
Total Assets
8.886.184.096.9913.4827.22

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Accounts Payable
4.814.652.580.04--
Accrued Expenses
0.951.170.60.260.260.39
Total Current Liabilities
5.765.823.190.290.260.39
Total Liabilities
5.765.823.190.290.260.39

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Common Stock
0.010.010.010.010.010.01
Additional Paid-In Capital
99.8587.4868.6757.0554.6760.47
Retained Earnings
-96.74-87.14-67.78-50.36-41.47-33.65
Total Common Equity
3.120.350.916.713.2126.83
Shareholders' Equity
3.120.350.916.713.2126.83
Total Liabilities & Equity
8.886.184.096.9913.4827.22

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Cash (Debt)
8.886.184.096.9913.4727.2
Net Cash Growth
184.03%50.98%-41.45%-48.10%-50.49%-4.16%
Net Cash Per Share
0.620.460.310.541.042.10
Filing Date Shares Outstanding
14.6814.6813.2712.8812.8512.95
Total Common Shares Outstanding
14.6814.313.1512.8512.8513.15
Working Capital
3.120.350.916.713.2126.82
Book Value Per Share
0.210.020.070.521.032.04
Tangible Book Value
3.120.350.916.713.2126.82
Tangible Book Value Per Share
0.210.020.070.521.032.04
SEC Filings: 10-K · 10-Q